0001104659-15-073439.txt : 20151028
0001104659-15-073439.hdr.sgml : 20151028
20151028133343
ACCESSION NUMBER: 0001104659-15-073439
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150930
FILED AS OF DATE: 20151028
DATE AS OF CHANGE: 20151028
EFFECTIVENESS DATE: 20151028
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 151179758
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
09-30-2015
09-30-2015
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
(415) 801-8100
/s/ Robin L. Praeger
San Francisco
CA
10-27-2015
0
7
174363358
false
INFORMATION TABLE
2
a15-21869_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
37465975
407416
SH
OTR
0
407416
0
Five Prime Therapeutics, Inc.
Common Stock
33830X104
16808219
1092152
SH
OTR
0
1092152
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
2034285
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
7379435
1281152
SH
OTR
0
1281152
0
Biotie Therapies Corp.
ADS
09074D103
3516916
268672
SH
OTR
0
268672
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
31148299
2215384
SH
OTR
0
2215384
0
Glaukos Corporation
Common Stock
377322102
76010229
3142217
SH
OTR
0
3142217
0